This free educational webinar is designed to help patients and providers understand how preimplantation genetic diagnosis (PGD) can be used as a powerful tool to end the cycle of hereditary cancer.

If you and/or your partner carry a hereditary cancer syndrome that could affect your future family, you may wish to undergo in vitro fertilization (IVF) with PGD. Find out if PGD is an option for you or your patients.

ORM Genomics, a division of Oregon Reproductive Medicine, uses the latest genomic technologies to aid patients with infertility in achieving success with fertility treatments and to help those who wish to reduce the chance that their children will have a specific genetic condition, such as a hereditary cancer syndrome.

This webinar is led by two of ORM’s reproductive and genetic experts: Elizabeth Barbieri, MD; Emily Mounts, MS, CGC

Topics Covered:
*Hereditary cancer syndromes
*Why patients choose to do PGD for hereditary cancer syndromes
*Examples of hereditary cancer syndromes for which PGD is possible
*In vitro fertilization (IVF) Overview
*PGD Overview
*Third party reproduction and PGD
*ORM’s clinic and embryology laboratory
*Comprehensive Chromosome Screening
*Patient stories and testimonials
*Myths about PGD

Register for this webinar today!

For more information about PGD: https://ormgenomics.com/preimplantation-genetic-diagnosis-pgd/

Learn more about Oregon Reproductive Medicine here: https://www.oregonreproductivemedicine.com/